Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 18Unknown 6Not yet recruiting 4Active not recruiting 4Recruiting 3Terminated 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Mesothelioma 1Adenomatous Polyposis Coli 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Exercise Therapy × Clear all
NCT06641310 2026-05-19

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

University of Michigan Rogel Cancer Center

Phase NA Recruiting
32 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT06831955 2026-03-20

LESLIE

Universitaire Ziekenhuizen KU Leuven

Phase 2 Recruiting
356 enrolled
Breast

Triple Negative Breast Neoplasms

NCT06491784 2024-07-09

EXTRA-Meso (EXercise TheRApy in Mesothelioma) Feasibility

NHS Greater Glasgow and Clyde

Phase NA Recruiting
40 enrolled
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡